Satsuma Pharmaceuticals Announces the Appointment of Thomas M. Soloway to its Board of Directors
SOUTH SAN FRANCISCO, Calif., July 07, 2020 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company, today […]